English  |  正體中文  |  简体中文  |  Post-Print筆數 : 11 |  Items with full text/Total items : 88613/118155 (75%)
Visitors : 23477982      Online Users : 649
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://nccur.lib.nccu.edu.tw/handle/140.119/109600


    Title: Destroying a Pharmaceutical Patent for Saving Lives? A Case Study of Sanofi-Synthelabo v. Apotex, Inc.
    Authors: 陳秉訓
    Chen, Ping-Hsun
    Contributors: 科智所
    Keywords: Abbreviated New Drug Application;antitrust;patent;generic drug
    Date: 2011-01
    Issue Date: 2017-05-15 15:48:40 (UTC+8)
    Abstract: In Sanofi-Synthelabo v. Apotex, Inc., both parties once intended to end the war. Maybe because the market of Plavix® is less competitive, both parties tried to avoid the expensive trial. Apotex was not worried about losing the exclusivity period, while Bristol-Myers Squibb thought of maintaining the monopoly. The antitrust law intervened to stop the scenario, which resulted in the indictment of the former vice president of Bristol-Myers Squibb. Though Apotex went on to fight against the patent as what the Act expected, Apotex finally lost. The drug market remained the same, and there have been no upcoming generic drug companies which want to challenge the patent at dispute. Definitely, the Act seems to underestimate the strength of brand-name drug patents and other negative impacts unnecessary patent litigation might give.
    Relation: Albany Law Journal of Science and Technology, Vol.21, No.1, pp.125-152.
    Data Type: article
    Appears in Collections:[科技管理與智慧財產研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML214View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback